Adaptive Biotechnologies Corporation - Common Stock (ADPT)
11.69
+0.64 (5.79%)
NASDAQ · Last Trade: Aug 6th, 6:33 PM EDT
Via Benzinga · August 5, 2025
Ark Invest traded in VCYT, IRDM, CRSP, KTOS, ABSI, VEEV, ADPT, and GH. Mainly focused on healthcare innovation.
Via Benzinga · July 26, 2025
Via Benzinga · June 21, 2025
Via Benzinga · June 18, 2025
ADAPTIVE BIOTECHNOLOGIES (ADPT) meets Minervini’s Trend Template with strong technicals and high-growth fundamentals, making it a compelling candidate for momentum investors.
Via Chartmill · June 14, 2025

Ark Invest made significant trades in TSLA, TXG, NTLA, DDD, and ADPT. Purchase of TXG and NTLA from ARKG and ARKK funds, and sale of TSLA, DDD, and ADPT from various funds.
Via Benzinga · May 30, 2025
ADAPTIVE BIOTECHNOLOGIES (ADPT) meets Minervini’s Trend Template with strong technicals and high growth momentum, making it a candidate for growth investors. The stock scores a perfect 10 on technical health but may need consolidation before an optimal entry.
Via Chartmill · May 13, 2025
Via Benzinga · May 5, 2025
Via Benzinga · May 2, 2025
Via Benzinga · May 2, 2025
On Wednesday, April 23, 2025, Cathie Wood of Ark Invest purchased more stock of AMD and Nvidia amid looming US chip curbs against China.
Via Benzinga · April 23, 2025
Via Benzinga · April 22, 2025
Via Benzinga · April 16, 2025
Via Benzinga · April 4, 2025
Via Benzinga · April 4, 2025
Via Benzinga · April 2, 2025
Via Benzinga · March 21, 2025
Via Benzinga · March 21, 2025

Small caps took another step down this past week as geopolitical events dampened sentiment.
Via Talk Markets · March 10, 2025